177 related articles for article (PubMed ID: 27216050)
1. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
[TBL] [Abstract][Full Text] [Related]
2. Intracellular metabolism and potential cardiotoxicity of a β-D-2'-
Tao S; Zhou L; Zhang H; Zhou S; Amiralaei S; Shelton J; Ehteshami M; Jiang Y; Amblard F; Coats SJ; Schinazi RF
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):204-224. PubMed ID: 31595843
[TBL] [Abstract][Full Text] [Related]
3. β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms.
Zhou L; Zhang HW; Tao S; Bassit L; Whitaker T; McBrayer TR; Ehteshami M; Amiralaei S; Pradere U; Cho JH; Amblard F; Bobeck D; Detorio M; Coats SJ; Schinazi RF
J Med Chem; 2015 Apr; 58(8):3445-58. PubMed ID: 25849312
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
Jin Z; Kinkade A; Behera I; Chaudhuri S; Tucker K; Dyatkina N; Rajwanshi VK; Wang G; Jekle A; Smith DB; Beigelman L; Symons JA; Deval J
Antiviral Res; 2017 Jul; 143():151-161. PubMed ID: 28412183
[TBL] [Abstract][Full Text] [Related]
5. Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.
Feng JY; Xu Y; Barauskas O; Perry JK; Ahmadyar S; Stepan G; Yu H; Babusis D; Park Y; McCutcheon K; Perron M; Schultz BE; Sakowicz R; Ray AS
Antimicrob Agents Chemother; 2016 Feb; 60(2):806-17. PubMed ID: 26596942
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides.
Arnold JJ; Sharma SD; Feng JY; Ray AS; Smidansky ED; Kireeva ML; Cho A; Perry J; Vela JE; Park Y; Xu Y; Tian Y; Babusis D; Barauskus O; Peterson BR; Gnatt A; Kashlev M; Zhong W; Cameron CE
PLoS Pathog; 2012; 8(11):e1003030. PubMed ID: 23166498
[TBL] [Abstract][Full Text] [Related]
7. Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.
Furman PA; Murakami E; Niu C; Lam AM; Espiritu C; Bansal S; Bao H; Tolstykh T; Micolochick Steuer H; Keilman M; Zennou V; Bourne N; Veselenak RL; Chang W; Ross BS; Du J; Otto MJ; Sofia MJ
Antiviral Res; 2011 Aug; 91(2):120-32. PubMed ID: 21600932
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA.
Lam AM; Espiritu C; Bansal S; Micolochick Steuer HM; Zennou V; Otto MJ; Furman PA
J Virol; 2011 Dec; 85(23):12334-42. PubMed ID: 21957306
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug.
Feng JY; Cheng G; Perry J; Barauskas O; Xu Y; Fenaux M; Eng S; Tirunagari N; Peng B; Yu M; Tian Y; Lee YJ; Stepan G; Lagpacan LL; Jin D; Hung M; Ku KS; Han B; Kitrinos K; Perron M; Birkus G; Wong KA; Zhong W; Kim CU; Carey A; Cho A; Ray AS
Antimicrob Agents Chemother; 2014; 58(4):1930-42. PubMed ID: 24419349
[TBL] [Abstract][Full Text] [Related]
10. Discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication.
Pinho P; Kalayanov G; Westerlind H; Rosenquist Å; Wähling H; Sund C; Almeida M; Ayesa S; Tejbrant J; Targett-Adams P; Eneroth A; Lindqvist A
Bioorg Med Chem Lett; 2017 Aug; 27(15):3468-3471. PubMed ID: 28622881
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase.
Ehteshami M; Zhou L; Amiralaei S; Shelton JR; Cho JH; Zhang H; Li H; Lu X; Ozturk T; Stanton R; Amblard F; McBrayer TR; Coats SJ; Schinazi RF
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559253
[TBL] [Abstract][Full Text] [Related]
12. HCV RdRp, sofosbuvir and beyond.
Feng JY; Ray AS
Enzymes; 2021; 49():63-82. PubMed ID: 34696839
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
Good SS; Moussa A; Zhou XJ; Pietropaolo K; Sommadossi JP
PLoS One; 2020; 15(1):e0227104. PubMed ID: 31914458
[TBL] [Abstract][Full Text] [Related]
14. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
[TBL] [Abstract][Full Text] [Related]
15. 2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.
Zhou S; Mahmoud S; Liu P; Zhou L; Ehteshami M; Bassit L; Tao S; Domaoal RA; Sari O; Schutter C; Amiralaei S; Khalil A; Ollinger Russell O; McBrayer T; Whitaker T; Abou-Taleb N; Amblard F; Coats SJ; Schinazi RF
J Med Chem; 2017 Jul; 60(13):5424-5437. PubMed ID: 28595015
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor.
Sizun G; Pierra C; Peyronnet J; Badaroux E; Rabeson C; Benzaria-Prad S; Surleraux D; Loi AG; Musiu C; Liuzzi M; Seifer M; Standring D; Sommadossi JP; Gosselin G
Future Med Chem; 2015; 7(13):1675-700. PubMed ID: 26424162
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties.
Kirschberg TA; Metobo S; Clarke MO; Aktoudianakis V; Babusis D; Barauskas O; Birkus G; Butler T; Byun D; Chin G; Doerffler E; Edwards TE; Fenaux M; Lee R; Lew W; Mish MR; Murakami E; Park Y; Squires NH; Tirunagari N; Wang T; Whitcomb M; Xu J; Yang H; Ye H; Zhang L; Appleby TC; Feng JY; Ray AS; Cho A; Kim CU
Bioorg Med Chem Lett; 2017 Apr; 27(8):1840-1847. PubMed ID: 28274633
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.
Fenaux M; Lin X; Yokokawa F; Sweeney Z; Saunders O; Xie L; Lim SP; Uteng M; Uehara K; Warne R; Gang W; Jones C; Yendluri S; Gu H; Mansfield K; Boisclair J; Heimbach T; Catoire A; Bracken K; Weaver M; Moser H; Zhong W
Antimicrob Agents Chemother; 2016 Dec; 60(12):7077-7085. PubMed ID: 27645237
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977.
Murakami E; Tolstykh T; Bao H; Niu C; Steuer HM; Bao D; Chang W; Espiritu C; Bansal S; Lam AM; Otto MJ; Sofia MJ; Furman PA
J Biol Chem; 2010 Nov; 285(45):34337-47. PubMed ID: 20801890
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
Murakami E; Bao H; Ramesh M; McBrayer TR; Whitaker T; Micolochick Steuer HM; Schinazi RF; Stuyver LJ; Obikhod A; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2007 Feb; 51(2):503-9. PubMed ID: 17101674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
